Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Allarity Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- 0 vs. Q1 2022
- Shares held
- 230.9K
- −108.9K (−32.1%) vs. Q1 2022
- Total value
- $304.0K
- −$390.0K (−56.2%) vs. Q1 2022
- New holders
- 1
- 3 more added
- Sold out
- 1
- 4 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALLR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $1.65M |
| Q1 2026 | 14 | $1.04M |
| Q4 2025 | 16 | $1.40M |
| Q3 2025 | 11 | $1.63M |
| Q2 2025 | 10 | $197.0K |
| Q1 2025 | 9 | $86.5K |
| Q4 2024 | 6 | $122.3K |
| Q3 2024 | 4 | $46.2K |
| Q2 2024 | 9 | $107.8K |
| Q1 2024 | 4 | $11.7K |
| Q4 2023 | 4 | $31.8K |
| Q3 2023 | 7 | $515.6K |
| Q2 2023 | 4 | $33.3K |
| Q1 2023 | 6 | $4.05K |
| Q4 2022 | 10 | $42.0K |
| Q3 2022 | 10 | $181.0K |
| Q2 2022 | 10 | $304.0K |
| Q1 2022 | 10 | $694.0K |
| Q4 2021 | 3 | $270.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Allarity Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 86,355 | $114.0K | 0.00% | −27,872−24.4% | Reduced |
| LMR Partners LLP | 46,033 | $61.0K | 0.00% | −5,345−10.4% | Reduced |
| Citigroup Inc | 32,559 | $43.0K | 0.00% | +22,483+223.1% | Added |
| Geode Capital Management, LLC | 29,433 | $38.0K | 0.00% | +17,118+139.0% | Added |
| Bridgeway Capital Management, LLC | 20,000 | $26.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 12,974 | $17.0K | 0.00% | +12,974 | New |
| UBS Group AG | 2,045 | $3.00K | 0.00% | −2,434−54.3% | Reduced |
| Bank of America Corp | 1,306 | $2.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 148 | $0 | 0.00% | −31,764−99.5% | Reduced |
| Wells Fargo & Company | 51 | $0 | 0.00% | +4+8.5% | Added |
| Millennium Management LLC | 0 | $0 | 0.00% | −94,082−100.0% | Sold out |